from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3624c/hpt

LFCtreatmentdescriptionclass of inhibitor

-2.303

Amikacinug/mL Amikacintranslation

-0.029

Cap5-10ug/mL Capreomycintranslation

-1.065

Rox10-50 ug/mL Roxithromycintranslation

0.098

SM2-5 ug/mL Streptomycintranslation

-2.733

Tet5-10 ug/mL Tetracyclinetranslation

-0.907

Rif0.2-5ug/mL Rifampicintranscription

-0.254

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.741

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.026

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.724

CPZ10-50 ug/mL Chlorpromazinerespiration

0.143

Clofazimine10-13 ug/mL Clofaziminerespiration

0.995

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.321

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.589

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.378

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

1.125

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.101

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.528

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.300

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.630

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.003

KCN5-20 ug/mL Potassium cyaniderespiration

1.391

NaN30.2-2 mM Sodium aziderespiration

0.461

Nigericin50 uM Nigericinrespiration

-0.796

TRC10-150 ug/mL Triclosanrespiration

-2.156

TRZ10-25 ug/mL Thioridazinerespiration

-1.907

Valinomycin0.5-10 uM Valinomycinrespiration

0.873

ZnSO42 mM ZnSO4respiration

-0.673

menadione6-10 ug/mL Menadionerespiration

0.088

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.921

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.264

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.945

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.374

NRP_1Non-replicating persistence stage 1dosRassociated

0.651

Amp0.2mg/mL AmpicillincellWall

0.250

Cephalexin20-100 ug/mL CephalexincellWall

0.099

Cerulenin0.32-5 ug/mL CerulenincellWall

0.216

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.403

EMB10-20 ug/mL EthambutolcellWall

0.525

Eta12-40 ug/mL EthionamidecellWall

0.732

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.239

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.250

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.523

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.020

BZA0.12 mg/mL BenzamidearomaticAmides

0.171

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.073

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.147

H2O24 mM hydrogen peroxideDNAdamaging

0.048

Levo10 ug/mL LevofloxacinDNAdamaging

0.721

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.269

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.079

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.329

UVUV-irradiationDNAdamaging

-0.547

ARP41-4 ug/mL Antitubercular compound ARP4?

1.126

Antimycin12.5-50 ug/mL Antimycin A?

0.771

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.568

PA_110-50 ug/mL Antitubercular compound PA-1?

0.898

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.201

PA8240.2-2 ug/mL PA-824?

-0.278

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.454

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.157

Verapamil50 uM Verapamil?

0.021

mercaptoethanol2 mM 2-Mercaptoethanol?

0.922

methoxatin10-20 ug/mL Methoxatin?